Champions Oncology, Inc. (CSBR)
Champions Oncology, Inc. (CSBR) is a provider of personalized cancer immunotherapy solutions. The company develops and offers patient-derived tumor models to help guide treatment decisions and accelerate drug development. Through its platform, Champions Oncology enables more effective and targeted cancer therapies by allowing researchers and clinicians to evaluate the efficacy of various treatments on individual patient samples.
Company News
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for mak...
Champions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -200% and 2.26%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?